# Herbalife Ltd. (HLF) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Consumer Defensive / Food & Staples Retailing. Price $12.38, market value $1.3 billion.

## Valuation
- **P/E (trailing): 7.9×** (5-yr avg 6.8×, 3-yr avg 6.4×). Herbalife Ltd. trades at 7.9× trailing earnings, close to its own five-year average of 6.8×. The Consumer Defensive median in the September 2026 study was 20.1×. Forward P/E is 4.0×, lower than trailing, so analysts expect earnings to grow.
- **Price / sales: 0.2×**. Each dollar of revenue is priced at 0.2×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **EV / EBITDA: 4.8×**. Enterprise value is 4.8× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: 25.1%** (5-yr avg 15.5%). Free cash flow equals 25.1% of the market value, above its five-year average of 15.5%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 12.6%**. The inverse of the P/E: 12.6% of the price is earned each year.

## Profitability
- **Gross margin: 77.7%**. Herbalife Ltd. keeps 77.7% of revenue after the direct cost of what it sells, the kind of margin that comes with software, brands or pricing power.
- **Operating margin: 9.5%**. 9.5% of revenue is left after running the business.
- **Net margin: 4.5%**. 4.5% of each dollar of sales reaches the bottom line.
- **Return on equity: -44.3%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: 34.6%**. Return on all capital, debt included, is 34.6%: comfortably above what that capital costs.
- **Return on assets: 5.9%**. Each dollar of assets produces 5.9% of profit.

## Growth
- **Revenue growth (1 yr): 0.9%** (3-yr -1.1%/yr, 5-yr -1.9%/yr). Revenue grew 0.9% over the last year, against -1.9% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): -12.0%** (3-yr -12.0%/yr, 5-yr -4.5%/yr). Earnings per share fell 12.0%, slower than revenue, so margins compressed.
- **Free-cash-flow growth (3 yr): 8.8%/yr**. Free cash flow has compounded at 8.8% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Net debt / EBITDA: 2.7×**. It would take 2.7 years of operating earnings to repay net borrowings, within the comfortable range.
- **Altman Z-score: 2.35**. A Z-score of 2.35 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Herbalife Ltd. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): 22.7%** (YTD -4.0%, 3-mo 8.3%). The shares are up 22.7% over twelve months including dividends.
- **From 52-week high: -39.3%** (63.8% above the low). Trading 39% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 52**. An RSI of 52 is neutral.
- **Beta (1 yr): 1.20** (volatility 60%). Beta of 1.20 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=HLF · Page: https://foliofundamentals.com/stocks/hlf

Not investment advice.